Status:
COMPLETED
Endoscopic Ultrasound Compared With Pancreatic Function Testing for Diagnosis of Chronic Pancreatitis
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
ChiRhoClin, Inc.
The National Pancreas Foundation
Conditions:
Chronic Pancreatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a investigator-initiated, single-center, prospective study to evaluate endoscopic ultrasound (EUS) as a diagnostic test for chronic pancreatitis (CP). EUS detects abnormalities of the pancreas...
Eligibility Criteria
Inclusion
- Male or female, age greater than 18 years.
- Capable of informed consent.
- If female and not more than 1 year post-menopausal, or surgically sterile, must use medically accepted form of contraception or abstain from sexual activities during study.
- EUS and CCK ePFT planned for a structural evaluation of the pancreas in patients with pancreatitis or pancreatic-type abdominal pain.
Exclusion
- Severe cardiac disease (stable or unstable angina, congestive heart failure, uncontrolled arrhythmias, implantable defibrillator, severe valvular disease, etc.).
- Severe pulmonary disease (Severe asthma, COPD or interstitial lung disease requiring nebulizer treatment or home oxygen, pulmonary hypertension).
- Severe renal disease (history of chronic renal insufficiency \[creatinine \>2.0\] or chronic hemodialysis).
- Inability to undergo conscious sedation or general anesthesia.
- Ongoing illicit drug use or abuse. Must be drug free for \>1 year.
- Acute pancreatitis within the past 2 months.
- Prior pancreatic surgery.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00651053
Start Date
May 1 2005
End Date
December 1 2007
Last Update
February 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195